Rocket Doctor AI Announces Strong Q3 2026 Patient Visit Growth and Expects Record Quarterly Revenue

The Company completed 53,348 patient visits across its U.S. and Canadian operations during the third quarter.

U.S. visits rose 56% from the prior quarter (Q2 2026), while Canadian visits increased 24% from the same quarter last year.

The results follow the Company’s September 14, 2026 operational update ( link ), with final quarterly U.S. visit volumes exceeding the preliminary indicators previously communicated.

“Our Q3 performance highlights the accelerating demand for Rocket Doctor AI’s physician-built, AI-powered platform across North America,” said Dr.

Essam Hamza, CEO of Rocket Doctor AI.

“Surpassing 50,000 total patient visits across Canada and the U.S. in a single quarter is a remarkable operational milestone.

The 56% quarter-over-quarter growth in completed U.S. visits demonstrates the successful rollout of our multi-payer strategy and expanding in-network coverage.

As we continue to scale our footprint and strengthen payor relationships, we are laying a strong foundation for sustainable, long-term revenue growth.

While U.S. patient volumes grew significantly in Q2, the associated revenue growth was not immediately reflected in our reported results because of the lag between patient visits, claims processing and cash collections.

With U.S. patient visits increasing a further 56% in Q3, we expect to begin seeing the financial benefits of that growth as collections catch up with clinical activity.

Our expectation of record Q3 revenue is an encouraging indication of that progression.” Read More